deltatrials
Completed PHASE2 INTERVENTIONAL 5-arm NCT02901275

Enhancing Medication-based Analgesia in Humans

Using Dronabinol to Enhance the Analgesic Effect of Hydromorphone in Humans

Sponsor: Johns Hopkins University

Conditions Cannabis Opioid Use, Unspecified Pain
Interventions Within-subject test of blinded study medications
Updated 16 times since 2017 Last updated: Nov 1, 2023 Started: Dec 31, 2016 Primary completion: Mar 23, 2020 Completion: Mar 23, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02901275, this PHASE2 trial focuses on Cannabis and Opioid Use, Unspecified and remains completed. Sponsored by Johns Hopkins University, it has been updated 16 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~May 2017 · 3 months · monthly snapshot~May 2017 – ~Dec 2017 · 7 months · monthly snapshot~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshot~Jun 2018 – ~Jan 2019 · 7 months · monthly snapshot~Jan 2019 – ~Nov 2019 · 10 months · monthly snapshot~Nov 2019 – ~Feb 2020 · 3 months · monthly snapshot~Feb 2020 – ~May 2020 · 3 months · monthly snapshot~May 2020 – ~Jan 2021 · 8 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Dec 2022 · 15 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Dec 2023 · 11 months · monthly snapshot~Dec 2023 – ~Jul 2024 · 7 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

16 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Dec 2023 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jan 2023 — Dec 2023 [monthly]

    Completed PHASE2

  5. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE2

▶ Show 11 earlier versions

  1. Sep 2021 — Dec 2022 [monthly]

    Completed PHASE2

  2. Jan 2021 — Sep 2021 [monthly]

    Completed PHASE2

  3. May 2020 — Jan 2021 [monthly]

    Completed PHASE2

    Status: Recruiting → Completed

  4. Feb 2020 — May 2020 [monthly]

    Recruiting PHASE2

  5. Nov 2019 — Feb 2020 [monthly]

    Recruiting PHASE2

  6. Jan 2019 — Nov 2019 [monthly]

    Recruiting PHASE2

  7. Jun 2018 — Jan 2019 [monthly]

    Recruiting PHASE2

  8. Dec 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

  9. May 2017 — Dec 2017 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  10. Feb 2017 — May 2017 [monthly]

    Not Yet Recruiting PHASE2

  11. Jan 2017 — Feb 2017 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Dec 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Johns Hopkins University
Data source: Johns Hopkins University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations